CUBE vs PYXS · P/E 25, rev $1.07B vs rev $2.8M
CubeSmart (CUBE) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the CUBE and PYXS stock pages for the full models.
Not investment advice.